Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

• Williams WB,
• Jones K,
• Krambrink A,
• Grove D,
• Liu P,
• Yates NL,
• Moody MA,
• Ferrari G,
• Pollara J,
• Moodie Z,
• Morgan CA,
• Liao H,
• Montefiori DC,
• Ochsenbauer C,
• Kappes J,
• Hammer S,
• Mascola J,
• Koup R,
• Corey L,
• Nabel G,
• Gilbert P,
• Churchyard G,
• Keefer M,
• Graham BS,
• Haynes BF,
• Tomaras GD

Affiliations

Williams WB

Jones K

Krambrink A

Grove D

Liu P

Yates NL

Moody MA

Ferrari G

Pollara J

Moodie Z

Morgan CA

Liao H

Montefiori DC

Ochsenbauer C

Kappes J

Hammer S

Mascola J

Koup R

Corey L

Nabel G

Gilbert P

Churchyard G

Keefer M

Graham BS

Haynes BF

Tomaras GD